Showing results (1-10 of 289) with videos related to
Sort By:
Pageof 29
Molecular Neuropsychiatry|November 27, 2019
Research Domain Criteria: Strengths, Weaknesses, and Potential Alternatives for Future Psychiatric ResearchChristopher A Ross, Russell L MargolisMolecular Neuropsychiatry|January 16, 2019
Research Domain Criteria: Cutting Edge Neuroscience or Galen's Humors Revisited?Christopher A Ross, Russell L MargolisClinical Chemistry|September 23, 2003
Diagnosis of Huntington diseaseRussell L Margolis, Christopher A RossHandbook of Clinical Neurology|September 27, 2017
Mechanisms underlying neurodegeneration in Huntington disease: applications to novel disease-modifying therapiesChristopher A Ross, Martin Kronenbuerger, Wenzhen Duan, et al.Movement Disorders : Official Journal of the Movement Disorder Society|May 4, 2011
Factors contributing to institutionalization in patients with Huntington's diseaseAdam Rosenblatt, Brahma V Kumar, Russell L Margolis, et al.Journal of Neuropathology and Experimental Neurology|April 2, 2008
A comparison of huntington disease and huntington disease-like 2 neuropathologyDobrila D Rudnicki, Olga Pletnikova, Jean-Paul G Vonsattel, et al.The Journal of Neuropsychiatry and Clinical Neurosciences|March 3, 2004
Cognitive impairment and psychiatric symptoms in 133 patients with diseases associated with cerebellar degenerationChristine M Liszewski, Elizabeth O'Hearn, Iracema Leroi, et al.Neuron|October 4, 2006
Neurobiology of schizophreniaChristopher A Ross, Russell L Margolis, Sarah A J Reading, et al.Movement Disorders : Official Journal of the Movement Disorder Society|July 13, 2013
Elevated arteriolar cerebral blood volume in prodromal Huntington's diseaseJun Hua, Paul G Unschuld, Russell L Margolis, et al.Movement Disorders : Official Journal of the Movement Disorder Society|December 17, 2011
Age, CAG repeat length, and clinical progression in Huntington's diseaseAdam Rosenblatt, Brahma V Kumar, Alisa Mo, et al.Pageof 29